Article Information
History
- August 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Patrick J. Tighe1,*,
- Richard A. Urbanowicz1,2,
- C. Lucy Fairclough1,
- C. Patrick McClure1,2,
- Brian J. Thomson3,4,
- Nancy Gomez1,
- Joseph G. Chappell1,2,
- Theocharis Tsoleridis1,2,
- Matthew Loose1,5,
- Matthew Carlile1,5,
- Christopher Moore1,5,
- Nadine Holmes1,5,
- Fei Sang1,5,
- Divyateja Hrushikesh6,
- Gemma Clark7,
- Nigel Temperton8,
- Tim Brooks9,
- Jonathan K. Ball1,2,4,
- William L. Irving1,2,4 and
- Alexander W. Tarr1,2,4,*
- 1School of Life Sciences, Faculty of Medicine and Health Sciences, The University of Nottingham, Nottingham, UK
- 2Wolfson Centre for Global Virus Infections, The University of Nottingham, Nottingham, UK
- 3School of Medicine, Faculty of Medicine and Health Sciences, The University of Nottingham, Nottingham, UK
- 4NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
- 5DeepSeq, Faculty of Medicine and Health Sciences, The University of Nottingham, Nottingham, UK
- 6Department of Clinical Chemistry, Nottingham University Hospitals NHS Trust, Nottingham, UK
- 7Department of Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
- 8Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent and University of Greenwich, Kent, UK
- 9Rare & Imported Pathogens Laboratory, Public Health England, Porton Down, Salisbury, UK
- ↵*Correspondence patrick.tighe{at}nottingham.ac.uk; alex.tarr{at}nottingham.ac.uk
Posted August 24, 2020.
Potent anti-SARS-CoV-2 Antibody Responses are Associated with Better Prognosis in Hospital Inpatient COVID-19 Disease
